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Background: Erythrocyte invasion by merozoites is an essential step in Plasmodium falciparum infection and leads
to subsequent disease pathology. Proteins both on the merozoite surface and secreted from the apical organelles
(micronemes, rhoptries and dense granules) mediate the invasion of erythrocytes; some of the molecules have
been regarded as targets in the development of an anti-malaria vaccine. Recently, a subgroup of rhoptry neck
proteins (PfRON2, PfRON4 and PfRON5) associated with the microneme protein apical membrane antigen AMA1 has
been described as components of the moving junction complex that assists merozoite invasion into erythrocytes.
However, unlike PfRON2, PfRON4 and PfRON5, the latest study suggested that PfRON3 might be located in the
rhoptry bulb and participates in a novel PfRON complex (PfRON2, 3 and 4), but does not form a complex with AMA1.
Additionally, the full-length PfRON3 protein possesses three transmembrane regions at the N-terminus, which is highly
conserved among RON3 orthologues in the genus Plasmodium, Toxoplasma gondii and Eimeria tenella. Overall, these
findings suggest that PfRON3 may play an important role in merozoite invasion into erythrocytes.
Results: PfRON3 was primarily expressed during the late trophozoite stage, with a peak in transcription levels at
40 hours post-invasion. The subcellular localization of PfRON3 was confirmed that it is a merozoite rhoptry bulb
protein. Additionally, the recombinant form of PfRON3 protein bound to the erythrocyte and was recognized by sera
collected from malaria endemic areas in Africa, and anti-PfRON3 antibodies significantly inhibited merozoite invasion
into erythrocytes.
Methods: The expression of PfRON3 was analysed via real-time quantitative PCR, and the recombinant PfRON3 proteins
were generated with an Escherichia coli expression system. The subcellular localization of PfRON3 was assessed with
immunoelectron microscopy and immunofluorescence assay (IFA). The recognition PfRON3 by malaria immune sera
was analysed with an enzyme-linked immunosorbent assay (ELISA). Erythrocyte-binding assays were performed using
recombinant PfRON3 proteins and invasion inhibition assays were carried out with PfRON3-specific antibodies.
Conclusion: This study confirmed that PfRON3 is a rhoptry protein with an erythrocyte-binding property, which is likely
associated red blood cell invasion. PfRON3 is a potential vaccine candidate.Background
Among the malaria parasites that infect humans,
Plasmodium falciparum is the most virulent parasite and
was responsible for over 600,000 deaths in 2013 worldwide
[1]. The pathogenesis of malaria occurs after the invasion
of erythrocytes by merozoites and the replication of
the obligate asexual intracellular parasites in the host
erythrocytes. The erythrocyte invasion process begins
with the attachment and proper re-orientation of the* Correspondence: jiangning@jlu.edu.cn; cqj@jlu.edu.cn
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merozoite surface proteins [2,3]. Subsequently, an electron
dense structure known as moving junction formed
between the merozoite apical end and the erythrocyte
membrane, involving rhoptry neck proteins and apical
membrane antigen 1 (AMA1) [4]. Using the actin-myosin
machinery, the merozoite pulls itself through the moving
junction and eventually forms a parasitophorous vacuole
inside the host erythrocyte [5]. During merozoite invasion
into the erythrocyte, several rhoptry neck proteins are
released and translocated onto the erythrocyte membrane
acting as AMA1 receptors [6-8]. Meanwhile, AMA1 istd. This is an Open Access article distributed under the terms of the Creative
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to form the RON-AMA1 complex. Recently, three of the
rhoptry neck proteins (PfRON 2, PfRON4 and 5) have
been reported to be involved in the complex formation
during invasion and bound to the micronemal protein
apical membrane antigen PfAMA1 in P. falciparum [9-11].
In Toxoplasma gondii, four of the rhoptry neck proteins
(TgRON2, TgRON4, TgRON5 and TgRON8) were found to
associate with the moving junction and bind to TgAMA1
[12-14]. However, the interaction of P. falciparum RON
proteins with AMA1 in the context of erythrocyte invasion
remains further investigations.
A recent study has indicated that PfRON3 does not
form complex with AMA1 but participates in a novel
PfRON complex (PfRON2, PfRON3 and PfRON4). Its
localization in the rhoptry body has been implicated [15],
but its association with merozoite invasion is unclear. In
this study, the expression of PfRON3 and its erythrocyte-
binding activity was systematically investigated. It was
found that PfRON3 bound to human red blood cell and




Plasmodium falciparum (strain 3D7) asexual stages were
maintained in human O+ erythrocytes with 5% serum
and 0.25% AlbuMAXII according to standard procedures
[16]. The parasites were synchronized by three rounds of
treatment with 5% sorbitol at 4 hours post-invasion and
parasites at 8, 16, 24, 32, 40, and 48 hours post-infection
were harvested.
Transcription analysis of the PfRON3 gene via real-time
quantitative PCR
Real-time quantitative PCR was carried out as previously
described [17]. Briefly, RNA corresponding to six time
points of post-invasion of the highly synchronized
parasites was extracted with TRIzol Reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
instructions. Following DNase treatment (TaKaRa, Dalian,
China), cDNA was synthesized with AMV reverse
transcriptase using an oligo(dT) primer. The following
primers were used for quantitative RT-PCR: forward,
5-TTC GCT TCC TTC ATC GGT GC and reverse,
5-TCG TAA AAT TCG GTT GGG GC. Quantitative
RT-PCR was performed using an ABI PRISM® 7500
Real-Time PCR System (Applied Biosystems) with
SYBR® Premix Ex TaqTM (TaKaRa). The seryl-tRNA
synthetase gene (PF3D7_1205100) which is stably
expressed during the erythrocytic stage of the parasite
was selected as the internal control and used for
normalization [18]. Analysis of the transcript levels
relative to the average level of the internal controlgene was calculated as 2-ΔΔCt(PfRON3 gene) [19]. The
experiment was repeated three times, and the mean
and standard error were determined.
Generation of PfRON3-specific antibodies
For generation of PfRON3-specific antibody, HIS-tagged
recombinant protein corresponding to region III of
PfRON3 (Figure 1) was produced. The 1,224 bp fragment
of the PfRON3 gene encoding a 408 amino acid fragment
(region III, aa 1372–1780), was PCR-amplified from
P. falciparum 3D7 strain blood–stage cDNA using
the following primers: forward primer, 5-gga tcc TTT
ACT AAT TTC TTA TTC TTA AGA AAC T and reverse
primer, 5-ctc gag TTT TGT TCC ATA GTT TTC TGT
ATT T. The amplicon was cloned into pET-32a
(Novagen, Dusseldorf, Germany) vectors and expressed in
Escherichia coli BL21 (DE3) [20]. The HIS-tagged re-
combinant PfRON3 protein (His-PfRON3-III) was purified
using His GraviTrap columns (GE Healthcare) accord-
ing to the manufacturer’s instructions. To generate
anti-PfRON3-III sera, three female New Zealand white
rabbits were immunized subcutaneously with 300 μg of
purified His-PfRON3-III protein emulsified with Freund’s
adjuvant. The immunizations were performed four times
at two-week intervals, and the antisera were collected
14 days after the final immunization.
To generate specific antibodies to MSP-1-42, the gene
fragment was amplified with primer MSP-1-42-F
(5′- gaattc CCA CAA CTG AAG ATG GGG GTC AC-3′)
and MSP-1-42-R (5′- ctcgag TGT AGA TGA TGT TCC
AGT TA-3′). The gene fragment was cloned into pET-32a,
and the recombinant protein (His-tagged PfMSP1-42) was
expressed and purified as described above. Four female
Wister rats respectively received four immunizations with
100 μg of purified His-tagged PfMSP1-42 protein emulsi-
fied with Freund’s adjuvant. The anti-PfMSP-1 antibodies
were used as controls. Specific IgG fractions of the immu-
nized rat and rabbit sera were affinity-purified with Protein
G SepharoseTM 4 Fast Flow (GE Healthcare) and Protein A
SepharoseTM 4 Fast Flow (GE Healthcare) according to the
manufacturer’s protocols.
Expression analysis of PfRON3 with SDS-PAGE and
Western blot assays
Schizont-rich parasites were harvested after 1% saponin
treatment. The parasite proteins were then solubilized in
SDS-PAGE loading buffer (250 mM Tris, 1.92 M glycine,
and 1% SDS), incubated at 98°C for 5 min and subjected
to electrophoresis under reducing conditions in a 12%
polyacrylamide gel. The proteins were transferred onto
0.2 μm nitrocellulose membranes (Bio-Rad, CA, USA)
using a semi-dry blotting system (Bio-Rad, CA, USA).
The membranes were blocked with 5% defatted milk
(Sigma, St Louis, USA) for one hour and then incubated
Figure 1 Schematic map of the primary structure of PfRON3. The PfRON3 protein contains 2215 amino acids with a calculated molecular
mass of 263.15 kDa. A predicted signal peptide (SP, residues 1 to 20), three transmembrane regions (TM, residues 250 to 272, 276 to 298 and 551
to 573), and a coiled-coil region (aa 1822 to 1847) are indicated with dark, grey and slashed bars. The regions (I, II, III, and IV) corresponding to
the four recombinant proteins generated are indicated underneath. The molecule is putatively divided into A, B and C regions based on the
location of SP and TM regions (also see the Additional file 2).
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were further incubated with horseradish peroxidase
conjugated secondary antibody (GE Healthcare) and
visualized with Immobilon Western Chemiluminescent
HRP Substrate (Millipore, Billerica, MA, USA) using a LAS
4000 mini luminescent image analyzer (GE Healthcare).
Localization of PfRON3 with specific antibodies in
immunofluorescence assay (IFA)
Thin smears of schizont stage P. falciparum-infected
erythrocytes were fixed with methanol at −80°C for
5 min, washed with PBST (PBS containing 0.1% Triton
X-100) at room temperature (RT) for 15 min, and then
blocked with PBS containing 5% defatted milk at 37°C
for one hour. The smears were then incubated with
rabbit anti-PfRON3 antibody (1:50 dilution) and a
control rat anti-MSP1-42 antibody at 37°C for one
hour, followed by incubation with both Alexa Fluor
488-conjugated goat anti-rabbit IgG (Invitrogen) and
Alexa Fluor 594-conjugated goat anti-rat IgG (Life)
secondary antibody (1:1,000) at 37°C for one hour. The
parasite nuclei were stained with DAPI (Roche, Basel,
Switzerland) at ambient temperature for 5 min. High-
resolution images were captured with a fluorescence
microscope (Olympus, BX 53).
Localization of PfRON3 with immunoelectronic
microscopy
Immunoelectronic microscopy was carried out as previously
described [15]. Briefly, parasites were fixed for 15 min
on ice in a mixture of 1% paraformaldehyde and 0.1%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4).
The fixed specimens were washed, dehydrated and
embedded in LR White resin (Fluka, 82882-1EA-F) as
described previously [21,22]. The ultra-thin sections were
blocked in PBS containing 5% defatted milk. The
grids were then incubated at 4°C overnight with
rabbit anti-PfRON3 or control IgG. After washing,
the grids were incubated at 37°C for one hour withgoat anti-rabbit IgG conjugated to 5 nm gold particles
(Sigma) with 1:40 dilutions. The grids were then rinsed with
distilled water, dried and stained with uranyl acetate and
lead citrate. The samples were examined using a transmis-
sion electronic microscope (Hitachi H-7650, Japan).
RBC-binding activity of PfRON3
To investigate the erythrocyte-binding activity of
PfRON3, GST-tagged PfRON3-I, II, III and IV (Figure 1),
and GST (negative control) were expressed in E. coli
BL21 [18] and purified on glutathione − sepharose. Primer
pairs for region I are PfRON3-I-F (5′- gga tcc AAT CTC
AGA CAATTATATAGA A) and PfRON3-I-R (5′-ctcgag
ACT GGA ATA TGG ATT ATT CAA TG). The primers
for region II are PfRON3-II-F (5′-ggatcc GAA AGA TAT
GGT GTT TTA AAA C) and PfRON3-II-R (5′-ctcgag
GGT ACC TTG GTG ATA AGT TTG TT). The primers
for region III are PfRON3-III-F (5′-ggatcc TTT ACT AAT
TTC TTT TTA AGA AAC T) and PfRON3-III-R
(5′-ctcgag TTT TGT TCC ATA GTT TTC TGT
ATT T), and the primers for region IV are PfRON3-IV-F
(5′-gaattc GAT CAA AGT ACA ACC GCT GATG) and
PfRON3-IV-R (5′-ctcgag TGG TCC ACC ATA TGC
TTT TTC AC). Next, 200 μl of human erythrocytes were
washed three times and resuspended in 200 μl of PBS.
Subsequently, 100 μg of recombinant proteins were mixed
with the erythrocytes respectively, and incubated at RT for
three hours. After incubation, the erythrocytes were
washed with PBS three times. Eventually, the proteins
that bound to erythrocytes were dissolved on a 10%
SDS-PAGE gel and detected via Western blot using
anti-GST IgG (Sungene Biotech, 1:5,000 dilution), which
was used to characterize GST-tagged proteins.
To test the erythrocyte-binding activity of the native
PfRON3, parasites at approximately 44 h post-invasion
were harvested by centrifugation at 1500 rpm and
washed 3 times with cold PBS. The parasites were lysed
by sonication in the presence of a cocktail of protease
inhibitors (Sigma). The solution was centrifuged 10 min
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bated with 100 μl erythrocytes at 37°C for 1 hour. The cells
were washed 3 times with PBS. The protein that bound to
erythrocytes was analysed by SDS-PAGE followed by
Western-blot using PfRON3 specific antibodies as
described above.
Immunorecognition of PfRON3 by human sera
The recognition of His-PfRON3 by human serum
samples collected from malaria-endemic regions in
Africa [23,24] was examined. ELISA plates (Nunc,
Rochester, NY, USA) were coated with the recombinant
protein (5 μg/ml, 50 μl per well) at 4°C overnight. The
plates were washed four times with PBS containing 0.05%
Tween 20. The coated wells were then blocked with 3%
BSA in PBS for one hour at 37°C and subsequently
washed four times. The malaria-infected serum samples
(n = 10) were added at 1:100, 1:200, 1:400 and 1:800
dilutions and incubated for one hour at 37°C. After wash-
ing four times, an alkaline phosphatase-conjugated goat
anti-human secondary antibody (Sigma, St Louis, USA)
was added at a 1:20,000 dilution and incubated at 37°C for
one hour. Finally, a substrate solution containing pNPP
[4-Nitrophenyl phosphate disodium salt hexahydrate]
(Sigma, St Louis, USA), 9.7% diethanolamine (pH 9.8) and
0.1 M magnesium chloride was added to the wells. A
human negative serum from a Chinese individual was
used as a negative control and TBST solution was used as
a blank control. The cutoff point of OD value for a
positive sample was set to be at least two times higher
than that of the negative sample at any dilution point. The
plates were read using a Biotek 93 micro-ELISA auto-
reader 808 at 405 nm. The experiment was repeated three
times and the OD405 values were represented by the mean
and standard error values of the three experiments.
Invasion inhibition assay with PfRON3 antibodies
The invasion inhibition activity of PfRON-specific
antibodies was tested in vitro as previously described
[25]. Briefly, PfRON3 specific IgG was purified from
rabbit antisera with Protein A-sepharose 4 Fast Flow
(GE Healthcare) as described above. Synchronized P.
falciparum cultures (ring stage) with 0.3% to 0.5%
parasitaemia and 5% haematocrit were incubated with
affinity-purified anti-PfRON3 IgG, anti-MSP1-42 IgG and
healthy rabbit IgG (negative control). The antibody
concentrations were 250, 150, 100, 50, and 10 μg/ml.
The inhibitory activity of the antibodies on merozoite
invasion was tested over two cycles of parasite replication.
Parasitaemia was determined via flow cytometry using a
FACS (BD FACS Aria cell sorter, CA, USA) and 50,000
cells were analysed in each experiment. The parasite
nuclei were stained with ethidium bromide (EB) and
tested in triplicates, the mean and standard errors weredetermined. The invasion inhibition efficiency of the con-
trol rabbit IgG was arbitrarily set as 0%, and the inhibition
efficiencies of the PfRON3 specific as well as that of the
MSP-1-42 specific antibodies were calculated by comparing
the parasitemia in the culture with the control IgG.
Results and discussion
The PfRON3 gene is primarily transcribed at the late
developmental stage of P. falciparum
One study early [15] indicated PfRON3 protein was
expressed at late stage of P. falciparum. To determine the
transcription of the PfRON3 gene during the blood-stage
of P. falciparum 3D7 strain, real-time quantitative PCR
analyses were performed by collecting highly synchronized
parasite cultures at eight-hour intervals. Transcription of
the PfRON3 gene was determined to start at approxi-
mately 24 hours and reached a peak at approximately
40 hours post-invasion (Additional file 1: Figure S1). The
data further confirmed the earlier reports that the PfRON
protein family is predominantly expressed at late schizont
stage [10,26].
The purification of recombinant proteins
To further characterise the potential function of PfRON3,
HIS-tagged recombinant protein (His-PfRON3-III) corre-
sponding to the third region of the molecule (Figure 1) was
expressed in E. coli, and purified via affinity chromatography
on His GraviTrap columns. The quality of the purified
recombinant protein was determined via 12% SDS–PAGE
(Figure 2A) and Western blotting analyses (Figure 2B). A
majority of the recombinant protein was in full-length,
with only a small proportion of degraded fragments as
seen in the Western-blot (Figure 2B). The recombinant
proteins were soluble, which made it possible for the gen-
eration of functional antibodies and erythrocyte-binding
assays.
The expression and localization of PfRON3
The expression of PfRON3 protein was analysed via
Western blot assay using an anti-PfRON3 antibody
with protein extracts of synchronized schizont parasites.
The antibody recognized a band larger than 250 kDa
corresponding to the full-length PfRON3 protein (the
molecular weight was estimated to be 263 kDa). A
band smaller than 250 kDa was also detected using
the anti-PfRON3 antibody (Figure 3A), which might
represent the degraded or processed form of PfRON3
during the invasion of merozoites into erythrocytes.
In the study of Ito et al. [15], the antibody primarily
recognized the second band, which was different from
ours. This could be due to the differences in the time
points of parasites collected or the antibodies used in the
two analyses. However, the data collectively indicated that
PfRON3 was processed after expression.
Figure 2 Generation and purity of recombinant PfRON3 protein. (A) SDS-PAGE analysis of purified His- PfRON3-III protein, which was
generated using an E. coli expression system. The purified His-PfRON3-III (66.1 kDa) protein was resolved on a 12% SDS-PAGE gel and stained with
Coomassie brilliant blue R-250. (B) Western blotting analysis of purified His-PfRON3-III protein under reducing conditions with anti-His-tag IgG.
The smaller bands are degraded products of the full-length protein.
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a dual label indirect immunofluorescence assay was
performed using a rabbit anti-PfRON3 antibody with
a rat anti-MSP1-42 (membrane marker) antibody as a
control. The IFA results showed that the location of
PfRON3 (green fluorescence) was distinct from that
of MSP1-42 (red fluorescence), which has been previously
confirmed as a merozoite surface protein (Figure 3B). The
IFA data showed that the localization of PfRON3 protein
was indeed distinct from membrane proteins and primarily
located inside merozoites.
A previous report indicated that PfRON3 may be
located in the rhoptry body [15]. In this study, the
location of PfRON3 was re-analysed with immunoEM.
Parasite sections in late schizont stages were incubated
with RON3-specific IgG and subsequently with a second-
ary antibody labelled with gold particles. Gold particle
signals were clearly detected in the bulb portion of the
rhoptries (Figure 3C). The data further confirmed that
PfRON3 is localized in the rhoptry bulb rather than the
rhoptry neck.
RON3 binds to human erythrocytes
Recombinant GST-tagged PfRON3-I, II, III, IV and GST
proteins were tested for erythrocyte-binding activity.Results (Figures 1 and 4) showed that only the GST-tagged
PfRON3-I protein, which corresponded the region between
the second and third TM of PfRON3, was found to bind
erythrocytes but not the other three regions. GST did not
show any binding to erythrocytes either (Figure 4B). The
erythrocyte-binding activity of PfRON3 was further con-
firmed with an assay where the native PfRON3 was found
to bind human erythrocytes in vitro (Figure 4C). The data
suggested that PfRON3 contains a region that mediates the
interaction between merozoites and human erythrocytes.
Further, the expression analyses in this study and that
reported by Ito et al. [15], two forms of PfRON3 were iden-
tified in the parasite, one was likely the full-length PfRON3,
and the other was around ≈ 80 kDa smaller than the whole
molecule. Here, it was found that only the smaller version
(≈180 kDa) of the molecule bound to erythrocytes, but not
the whole molecule. This indicated that PfRON3 was most
likely protelytically processed before it was released from
the rhoptry organelle (Additional file 2: Figure S2). Only
the smaller form of the molecule binds red blood cell.
Additionally, previous studies suggested that PfRON2
and PfRON5 could bind to the RBC membrane and
thereby served as a parasite-specific receptor of the
AMA1 complex during invasion [27,28]. The data of this
study not only confirmed the reported by Zhang et al.
Figure 3 The expression and localization of PfRON3 in Plasmodium falciparum merozoites. (A) Detection of PfRON3 in schizonts. Lanes 1
and 2 represent healthy human red blood cells (negative control) and schizont-rich stage parasites. Two bands of approximately 260 and 180 kDa
were detected in the schizont stage of the parasites (arrow-headed). (B) PfRON3 is expressed inside Plasmodium merozoites. Schizont stage
parasites were dual-labeled with PfRON3-specific antibodies in combination with MSP1-42 antibodies. Nuclei are stained with DAPI. MSP1-42
protein was located at the merozoite membrane (red fluorescence) and RON3 was located inside merozoites (green fluorescence). (C) PfRON3
location shown via immunoelectronic microscopy. The section of merozoite in mature schizonts was labeled with purified rabbit anti-PfRON3
antibodies and subsequently detected with a secondary antibody conjugated with gold particles (arrow-headed). The black dots indicate signals
from gold particles localized in the rhoptry body. Bar represents 200 nm.
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in the early phase of erythrocyte invasion. Thus, a majority
of the PfRON proteins are erythrocyte-binding proteins
participating in the interaction of the invading merozoite
and erythrocytes.
PfRON3 was recognized by the antibodies of individuals
living in malaria-endemic regions and anti-PfRON3
antibodies inhibited merozoite invasion
Invasion into human erythrocytes is the first step for the
establishment of infection and successful transmission ofFigure 4 Erythrocyte-binding activity of PfRON3 proteins. (A) SDS-PAG
(52 kDa), RON2-II (54 kDa), RON3-III (74.1 kDa), RON3-IV (55.7 kDa) and GST
with Coomassie brilliant blue R-250 are shown. (B) Western blot analysis of
PfRON3 proteins. The proteins were mixed with human erythrocytes separate
The results show that only the recombinant PfRON3-I protein could bind to h
with human red blood cells. Soluble parasite proteins were incubated with hu
specific antibody in Western-blot. The antibody only recognized the protein (the malaria parasites. Thus immune responses to
parasite ligands participating in the invasion process
will provide the first line immunity against malaria
disease. Here the importance of PfRON3 as an im-
munogen during parasite infection was investigated in
two approaches. First, the recombinant PfRON3 was
tested for the recognition by the antibodies in the
malaria immune individuals, and it was found that
PfRON3 was well recognized by the sera of individ-
uals living in the malaria endemic region (Figure 5A).
Secondly, the antibodies to PfRON3 were found toE analysis of purified GST-tagged PfRON3 proteins. The purified RON3-I
(26 kDa) proteins were resolved in 12% SDS-PAGE gels and stained
the erythrocyte-binding activity of the recombinant GST-tagged
ly and the binding was subsequently detected with a GST-specific mAb.
uman erythrocytes. (C) Detection of the binding of the native PfRNO3
man RBC and the binding of PfRON3 with RBC was detected with a
PfRON3) (lane 2), but not reacted with any protein of RBC (lane 1).
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as anti-MSP-1 antibody (Figure 5B). The data collect-
ively indicated that PfRON3 is a molecule playing an
important role in the process of erythrocyte invasion and
immune responses to this antigen would likely provide
certain immunity against severe malaria. Considering
the importance of the PfRON complex in the mero-
zoite invasion of erythrocytes and its high sequence
similarity between different parasite strains/isolates,
PfRON3 should be further investigated as a potential
vaccine candidate.Figure 5 Immunogenicity of PfRON3 and invasion inhibition of PfRON
of individuals living a malaria endemic area was analyzed via ELISA assay. T
well recognized by the antibodies in the sera, while the negative control se
standard error values of the three experiments. (B) The inhibitory effect of
and anti-MSP1-42 specific IgG were diluted in concentrations ranging from
control. The results show that PfRON3- and MSP-1-specific IgG inhibited paras
rabbit IgG had no inhibitory effect at any concentrations. The bars represent tConclusions
The data of this study indicate that the PfRON3 gene was
primarily transcribed at the late schizont stage, and the
encoded PfRON3 is mainly localized in the rhoptry bulb,
which is likely to be released and bind erythrocyte upon
the interaction of the anterior end of a merozoite with the
surface of an erythrocyte. PfRON3 is recognized by the
antibodies of individuals living in malaria endemic
areas. Importantly, PfRON3-specifc antibodies inhibited the
parasite invasion into erythrocytes, thereby suggesting that
PfRON3 could be a potential malaria vaccine candidate.3-specific antibodies. (A) Immunorecognition of PfRON3 by the sera
he sera were diluted at 1:100 to 1:800. The results show that PfRON3 is
ra did not react with the protein. The bars represent the mean and
PfRON3-specific IgG on merozoite invasion was tested. Anti-PfRON3
10 to 250 μg/ml. IgG from healthy rabbits was used as a negative
ite proliferation in a dose-dependent manner. Meanwhile, the control
he mean and standard error values of the three experiments.
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Additional file 1: Transcription of PfRON3 gene in the Plasmodium
falciparum 3D7 clone at different developmental stages. The
transcription levels of the PfRON3 gene at 8, 16, 24, 32, 40 and 48 hours
p.i. were detected by QPCR. The transcription level at 16 hour was the
lowest; the fold changes presented in the figure were all relative to that
of 16 hour. The values of the fold changes were calculated by 2-ΔΔCt.
Additional file 2: Putative model of the location of PfRON3 after
merozoite release. The N-terminal region (A, indicated with dashed line)
of PfRON3 was likely protelytically processed. The region B, associated
with RBC-binding during merozoite invasion, might be located outside
the parasite or parasitophorous vacuole membrane (PVM), while the
region C is located inside the merozoite or PMV.
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